Big Pharma is Toast. The_Days_of_Selling_Poision_Are_Over.
Phase 1 -Complete NASDQ -Complete
When the market begins to understand, OCAT will rise in billion dollar increments of market cap.
Cellular medicine is a new dawn.
In 6 months the phase 2 data will trickle in, the market will move before that.
This is a new branch of science and medicine. And Ocata has the IP to go it alone. They have $20 million, and they've made it clear that they only needed $40 million for their next phase 2.
They can begin and get well into it with what they have already.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.